Neonates, Sepsis, and Antimicrobial Resistance-Steps to Tackle Difficult Issues in Our Most Vulnerable Population.

Guitart, Chloé; Peters, Alexandra; Lotfinejad, Nasim; Pittet, Didier

Guitart, Chloé; Peters, Alexandra; Lotfinejad, Nasim; Pittet, Didier.

Afiliação

Guitart C; Infection Control Programme, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.
Peters A; Infection Control Programme, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.
Lotfinejad N; Department of Research, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Pittet D; Infection Control Programme, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland. Electronic address: didier.pittet@hcuge.ch.

J Obstet Gynaecol Can ; 43(4): 425-426, 2021 04.

Article em En | MEDLINE | ID: mdl-32622545

Assuntos

Antibacterianos/uso terapêutico; Sepse Neonatal/tratamento farmacológico; Farmacorresistência Bacteriana; Humanos; Recém-Nascido; Sepse Neonatal/microbiologia; Populações Vulneráveis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sepse Neonatal / Antibacterianos Limite: Humans / Newborn Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google